The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial

• Main Authors: Elham Karimi, Javad Heshmati, Nooshin Shirzad, Samira Vesali, Mohammad Javad Hosseinzadeh-Attar, Ashraf Moini, Mahdi Sepidarkish
• Format: Article
• Language: English
• Published: BMC 2020-04-01
• Series: Lipids in Health and Disease
• Subjects: Polycystic ovary syndrome; Synbiotics; Cholesterol, LDL; Cholesterol, HDL; Triglycerides
• Online Access: http://link.springer.com/article/10.1186/s12944-020-01244-4

Abstract Background Different therapies have been suggested for polycystic ovary syndrome (PCOS), but changes in lifestyle and diet have been considered. Diet and dietary factors can be very effective in modifying the disease. The positive effects of probiotic and synbiotics supplementation on improving lipid profiles and anthropometric indices have been examined in various diseases. This study was conducted to evaluate the effects of synbiotics supplementation on lipid and anthropometric profiles in infertile women with PCOS. Methods PCOS patients aged 19–37 years old were randomized to receive either synbiotics supplement (n = 50) or placebo (n = 49) for 12 weeks. Results Consumption of synbiotics compared to the placebo, resulted in a significant decrease in Low-density lipoprotein cholesterol (LDL) value (Change Mean Difference (CMD): 4.66, 95%CI: 0.20, 9.13) and a significant increase in high-density lipoprotein cholesterol (HDL) (CMD: 1.80, 95%CI: 0.34, 3.26). Although we failed to find a significant effect of synbiotics consumption on total cholesterol (TC) and triglyceride (TG) levels. We did not find differences in anthropometric indices between groups. Conclusions Overall, 12 weeks of synbiotics supplementation among PCOS women resulted in beneficial effects on LDL and HDL, although it is not yet clear how much our findings are clinically significant and more clinical studies with larger sample sizes are still needed. Trial registration Iranian Registry of clinical Trial, IRCT.ir, ID: IRCT2014110515536N2 . Registered on 19 December 2015. Graphical abstract